These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8568321)

  • 1. Silver iontophoretic catheter: a prototype of a long-term antiinfective vascular access device.
    Raad I; Hachem R; Zermeno A; Stephens LC; Bodey GP
    J Infect Dis; 1996 Feb; 173(2):495-8. PubMed ID: 8568321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin.
    Raad I; Darouiche R; Hachem R; Mansouri M; Bodey GP
    J Infect Dis; 1996 Feb; 173(2):418-24. PubMed ID: 8568304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulfadiazine in critically ill patients.
    Carrasco MN; Bueno A; de las Cuevas C; Jimenez S; Salinas I; Sartorius A; Recio T; Generelo M; Ruiz-Ocaña F
    Intensive Care Med; 2004 Apr; 30(4):633-8. PubMed ID: 14722639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia.
    Heard SO; Wagle M; Vijayakumar E; McLean S; Brueggemann A; Napolitano LM; Edwards LP; O'Connell FM; Puyana JC; Doern GV
    Arch Intern Med; 1998 Jan; 158(1):81-7. PubMed ID: 9437382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of coagulase-negative staphylococcal nosocomial bloodstream isolates to the chlorhexidine/silver sulfadiazine-impregnated central venous catheter.
    Rosato AE; Tallent SM; Edmond MB; Bearman GM
    Am J Infect Control; 2004 Dec; 32(8):486-8. PubMed ID: 15573055
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged antimicrobial activity of a catheter containing chlorhexidine-silver sulfadiazine extends protection against catheter infections in vivo.
    Bassetti S; Hu J; D'Agostino RB; Sherertz RJ
    Antimicrob Agents Chemother; 2001 May; 45(5):1535-8. PubMed ID: 11302823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients.
    Sheng WH; Ko WJ; Wang JT; Chang SC; Hsueh PR; Luh KT
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):1-5. PubMed ID: 11025176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization.
    Walz JM; Avelar RL; Longtine KJ; Carter KL; Mermel LA; Heard SO;
    Crit Care Med; 2010 Nov; 38(11):2095-102. PubMed ID: 20711070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
    Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
    N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antimicrobial efficacy of silver iontophoretic catheter.
    Raad I; Hachem R; Zermeno A; Dumo M; Bodey GP
    Biomaterials; 1996 Jun; 17(11):1055-9. PubMed ID: 8718964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorhexidine-silver sulfadiazine-impregnated central venous catheters: in vitro antibacterial activity and impact on bacterial adhesion.
    Monzillo V; Corona S; Lanzarini P; Dalla Valle C; Marone P
    New Microbiol; 2012 Apr; 35(2):175-82. PubMed ID: 22707130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine.
    Greenfeld JI; Sampath L; Popilskis SJ; Brunnert SR; Stylianos S; Modak S
    Crit Care Med; 1995 May; 23(5):894-900. PubMed ID: 7736748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi.
    Raad I; Mohamed JA; Reitzel RA; Jiang Y; Raad S; Al Shuaibi M; Chaftari AM; Hachem RY
    Antimicrob Agents Chemother; 2012 Feb; 56(2):935-41. PubMed ID: 22123686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an in vitro urinary tract model.
    Gaonkar TA; Sampath LA; Modak SM
    Infect Control Hosp Epidemiol; 2003 Jul; 24(7):506-13. PubMed ID: 12887239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of ultrasonic-induced chlorhexidine liberation: correlation of the activity of chlorhexidine-silver-sulfadiazine-impregnated catheters to agar roll technique and broth culture.
    Schierholz JM; Bach A; Fleck C; Beuth J; König D; Pulverer G
    J Hosp Infect; 2000 Feb; 44(2):141-5. PubMed ID: 10662565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an antimicrobial-impregnated continuous ambulatory peritoneal dialysis catheter for infection control in rats.
    Kim CY; Kumar A; Sampath L; Sokol K; Modak S
    Am J Kidney Dis; 2002 Jan; 39(1):165-73. PubMed ID: 11774116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
    Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
    Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters.
    Sampath LA; Tambe SM; Modak SM
    Infect Control Hosp Epidemiol; 2001 Oct; 22(10):640-6. PubMed ID: 11776351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters.
    Hanna H; Bahna P; Reitzel R; Dvorak T; Chaiban G; Hachem R; Raad I
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3283-8. PubMed ID: 17005806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.